Home Cart Sign in  
Chemical Structure| 1456551-16-8 Chemical Structure| 1456551-16-8

Structure of JG-98
CAS No.: 1456551-16-8

Chemical Structure| 1456551-16-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor which shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of JG-98

CAS No. :1456551-16-8
Formula : C24H21Cl2N3OS3
M.W : 534.54
SMILES Code : O=C1N(CC)/C(S/C1=C2SC3=CC(Cl)=CC=C3N/2C)=C/C4=[N+](CC5=CC=CC=C5)C=CS4.[Cl-]
MDL No. :MFCD32067914
InChI Key :AUPPGWXGMILTRB-HDPAMLMOSA-M
Pubchem ID :72547053

Safety of JG-98

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of JG-98

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
IPSC-CMs 12.1 µM JG98 significantly reduced MyBP-C protein levels PMC10544073
Mouse embryonic fibroblasts (MEFs) 4.2 ± 1 μM Evaluate the toxicity of JG-98 on MEFs PMC6104643
MDA-MB-231 cells 0.39 ± 0.03 μM Evaluate the anti-proliferative activity of JG-98 on MDA-MB-231 cells PMC6104643
MCF-7 cells 0.71 ± 0.22 μM Evaluate the anti-proliferative activity of JG-98 on MCF-7 cells PMC6104643
HCT116 cells IC50 of 0.50-0.74 μM 48 h JG-98 exhibited high inhibitory activity against HCT116 cells with an IC50 of 0.50-0.74 μM. PMC7244387
AsPC-1 cells IC50 of 0.60-0.86 μM 48 h JG-98 exhibited high inhibitory activity against AsPC-1 cells with an IC50 of 0.60-0.86 μM. PMC7244387
MIA PaCa-2 cells IC50 of 0.25-0.65 μM 48 h JG-98 exhibited high inhibitory activity against MIA PaCa-2 cells with an IC50 of 0.25-0.65 μM. PMC7244387
HeLa 0.3-4 μM 72 h To evaluate the anti-proliferative activity of JG-98, results showed that JG-98 has anti-proliferative effects on multiple cancer cell lines PMC4456214
MCF-7 0.3-4 μM 72 h To evaluate the anti-proliferative activity of JG-98, results showed that JG-98 has anti-proliferative effects on multiple cancer cell lines PMC4456214
MCF7 0–1.5 µM 72 h Investigate the effect of JG-98 on MCF7 cells, results showed that the combination of JG-98 with MA significantly enhanced the anticancer effect PMC8229576
A549 0–1.5 µM 72 h Investigate the effect of JG-98 on A549 cells, results showed that the combination of JG-98 with MA significantly enhanced the anticancer effect PMC8229576
NCI-H23 0–1.5 µM 72 h Investigate the effect of JG-98 on NCI-H23 cells, results showed that the combination of JG-98 with MA significantly enhanced the anticancer effect PMC8229576
NCI-H1299 0–1.5 µM 72 h Investigate the effect of JG-98 on NCI-H1299 cells, results showed that the combination of JG-98 with MA significantly enhanced the anticancer effect PMC8229576
H1299 cells 1 µM To investigate the effect of Hsp70 inhibition on autophagy, results showed that Hsp70 inhibition enhanced autophagic flux. PMC11354248
A549 cells 1 µM To investigate the effect of Hsp70 inhibition on autophagy, results showed that Hsp70 inhibition enhanced autophagic flux. PMC11354248
Her2-transformed MCF10A cells 1μM 24 h Her2-transformed cells were more sensitive to JG-98, showing stronger induction of UPR genes and more significant phosphorylation of eIF2α. PMC9097715
MCF10A cells 1μM 12 h RNAseq analysis revealed that JG-98 activated UPR-related genes, particularly phosphorylation of eIF2α. PMC9097715
MDA-MB231 2 μM 24 h Using ActivSignal's IPAD technology, it was found that JG-98 suppressed NF-kB, FAK-Src, Notch, and WNT pathways while activating mTOR and MAPK pathways in MDA-MB231 cells. PMC5813176
MCF7 2 μM 36 h Microarray analysis revealed that JG-98 downregulated 176 pathways and upregulated 19 pathways in MCF7 cells. PMC5813176

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice MIA PaCa-2 xenograft model Intraperitoneal injection 2 and 4 mg/kg Administered every other day for 12 doses JG-231 significantly suppressed the growth of MIA PaCa-2 xenografts without causing significant loss of. PMC7244387
Mice NSG mice Intraperitoneal injection 3 mg/kg Twice a week for 2 weeks To evaluate the pharmacokinetics, tolerability, and activity of JG-98 in two xenograft models, results showed that JG-98 inhibited tumor growth in both models PMC4456214
Mice TT and MZ-CRC-1 xenograft models Intraperitoneal injection 4 mg/kg Every other day, for a total of 10 doses To evaluate the effect of JG-231 on TT and MZ-CRC-1 xenograft models, results showed that JG-231 significantly suppressed tumor growth. PMC8835675
Nude mice MDA-MB231 xenograft model Subcutaneous injection 5 mg/kg Not specified In the MDA-MB231 xenograft model, JG-98 significantly suppressed tumor growth, and the effect was more pronounced when combined with bortezomib. PMC5813176

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.87mL

0.37mL

0.19mL

9.35mL

1.87mL

0.94mL

18.71mL

3.74mL

1.87mL

References

 

Historical Records

Categories